United States· US:46287-012_ad780ec6-1a7e-4838-b833-6adb6bdbdb9a
Sodium Polystyrene Sulfonate
A medicinal product containing sodium polystyrene sulfonate, registered in United States by CMP Pharma, Inc..
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- SODIUM POLYSTYRENE SULFONATE
- Manufacturer
- CMP Pharma, Inc.
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 2
- ndc1146287-012-16
- ndc114628701216454 g in 1 JAR (46287-012-16)
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Sodium polystyrene sulfonate in 7 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CanadaJAMP SODIUM POLYSTYRENE SULFONATEJAMP PHARMA CORPORATION
- GermanyAnti-Kalium NaMedice Arzneimittel Pütter Gmbh & Co. Kg
- Japanポリスチレンスルホン酸ナトリウム扶桑薬品工業
- FrancePOLYSTYRENE SULFONATE DE SODIUM SUBSTIPHARM 454 g, poudre pour suspension orale et rectaleSUBSTIPHARM
- United KingdomResonium A powderSanofi
- BelgiumKayexalate Sodium 14.99 gSanofi Belgium
- FinlandResoniumSanofi Oy
Authorised across Europe · EMA
The same active substance is authorised in 15 EEA countries. Names it is sold under:
- Austria · Resonium A
- Belgium · Kayexalate Sodium
- Cyprus · Resinsodio
- Germany · Anti-Kalium Na, Elutit®-Natrium-As
- Spain · Resinsodio
- Finland · Resonium
- France · Kayexalate, Lykasty
- United Kingdom (Northern Ireland) · Resonium A
- Hungary · Resonium
- Italy · Kayexalate
- Luxembourg · Kayexalate Sodium
- Netherlands · Natriumpolystyreensulfonaat Focus, Resonium A
- Poland · Resonium A
- Portugal · Resonium
- Sweden · Resonium
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/c91a96ff-71cb-45b5-82db-4d2c4cc580c1 GET /v1/drugs/c91a96ff-71cb-45b5-82db-4d2c4cc580c1?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "ORAL; RECTAL",
"source": "ndc",
"strength": "1",
"substance": "SODIUM POLYSTYRENE SULFONATE",
"productndc": "46287-012",
"dosage_form": "POWDER, FOR SUSPENSION",
"dea_schedule": null,
"strength_unit": "g/g",
"application_number": "ANDA089910",
"marketing_category": "ANDA"
}See everything about sodium polystyrene sulfonate.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.